Clinical Trial Update: Docetaxel and Gemcitabine in Treating Patients With Progressive Regional or Metastatic Bladder Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating docetaxel and gemcitabine in progressive regional or metastatic bladder cancer and related transitional cell cancers; study is complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Transitional Cell Cancer of the Renal Pelvis and Ureter
• Urethral Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter | Phase 2 | Status: COMPLETED